Evaluation on the incidence, mortality and tendency of lung cancer in China
- PMID: 27755783
- DOI: 10.1111/j.1759-7714.2010.00011.x
Evaluation on the incidence, mortality and tendency of lung cancer in China
Abstract
Objective: To analyze lung cancer epidemiological trends and estimate the lung cancer burden in China.
Methods: The age-specific mortality/incidence ratios in different geographical areas and for both sexes for lung cancer were obtained from the National Cancer Registration database in 2004 and 2005. Cancer crude mortality rates were retrieved from the database of the third national death survey from 2004-2005. Age-specific incidence rates of lung cancer were calculated using mortality and mortality/incidence ratios. The annual percent change was estimated with a log regression model using joinpoint software analyzing pooled lung cancer incidence data from 10 cancer registries from 1988 to 2005.
Results: The total estimated new lung cancer cases and deaths in 2005 were 536 407 and 475 768 respectively, the numbers were higher for men than for women, and show an increase of 1.63% annually from 1988 to 2005. However, the trend showed a slowdown of 0.55% after being adjusted for age.
Conclusions: Lung cancer is one of the major health issues in China and the burden is getting serious. Aging is the main cause for the increasing incidence and mortality of lung cancer. Effective cancer prevention and control is imperative. Tobacco control especially should be implemented in nationwide.
Keywords: Cancer registry; China; epidemiology; incidence; lung cancer; mortality.
© Tianjin Lung Cancer Institute and Blackwell Publishing Asia Pty. Ltd.
Similar articles
-
[Estimation and projection of lung cancer incidence and mortality in China].Zhongguo Fei Ai Za Zhi. 2010 May;13(5):488-93. doi: 10.3779/j.issn.1009-3419.2010.05.20. Zhongguo Fei Ai Za Zhi. 2010. PMID: 20677647 Free PMC article. Chinese.
-
[The incidence and mortality of lung cancer in China, 2014].Zhonghua Zhong Liu Za Zhi. 2018 Nov 23;40(11):805-811. doi: 10.3760/cma.j.issn.0253-3766.2018.11.002. Zhonghua Zhong Liu Za Zhi. 2018. PMID: 30481929 Chinese.
-
[Estimation of cancer incidence and mortality in China in 2004-2005].Zhonghua Zhong Liu Za Zhi. 2009 Sep;31(9):664-8. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 20021861 Chinese.
-
Lung cancer molecular epidemiology in China: recent trends.Transl Lung Cancer Res. 2014 Oct;3(5):270-9. doi: 10.3978/j.issn.2218-6751.2014.09.01. Transl Lung Cancer Res. 2014. PMID: 25806311 Free PMC article. Review.
-
Some features of lung cancer in China.Lung Cancer. 1993 Oct;10(1-2):107-16. doi: 10.1016/0169-5002(93)90316-p. Lung Cancer. 1993. PMID: 8069599 Review.
Cited by
-
[Clinical utility of serum tumor markers in lung cancer].Zhongguo Fei Ai Za Zhi. 2011 Mar;14(3):286-91. doi: 10.3779/j.issn.1009-3419.2011.03.16. Zhongguo Fei Ai Za Zhi. 2011. PMID: 21426676 Free PMC article. Review. Chinese.
-
Case-Control Study on Impact of the Telomerase Reverse Transcriptase Gene Polymorphism and Additional Single Nucleotide Polymorphism (SNP)- SNP Interaction on Non-Small Cell Lung Cancers Risk in Chinese Han Population.J Clin Lab Anal. 2016 Nov;30(6):1071-1077. doi: 10.1002/jcla.21982. Epub 2016 May 7. J Clin Lab Anal. 2016. PMID: 27154632 Free PMC article.
-
Genetic variation in the TP63 gene is associated with lung cancer risk in the Han population.Tumour Biol. 2014 Mar;35(3):1863-6. doi: 10.1007/s13277-013-1248-3. Epub 2013 Oct 4. Tumour Biol. 2014. PMID: 24092572
-
Correlation of CLPTM1L polymorphisms with lung cancer susceptibility and response to cisplatin-based chemotherapy in a Chinese Han population.Tumour Biol. 2014 Dec;35(12):12075-82. doi: 10.1007/s13277-014-2508-6. Epub 2014 Aug 26. Tumour Biol. 2014. PMID: 25155038
-
An elderly patient with advanced lung cancer achieved long-term survival using Chinese medicine: An alternative treatment strategy for cancer patients aged 80 or older without a tissue confirmed diagnosis.Chin J Integr Med. 2016 Jul;22(7):545-8. doi: 10.1007/s11655-015-2309-9. Epub 2015 Nov 23. Chin J Integr Med. 2016. PMID: 26597286 No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical